| ★ | Furoscix ReadyFlow (Furosemide) and its Impact on HF, CKD Edema Treatment | | 374 | Estados Unidos | |
| 9 | Cardio - Renal Syndrome : A Clear and Practical Medical Overview | Medical Centric Podcast @medicalcentric | — | Portugal | 84 |
| 16 | HFpEF : The Forgotten Heart Failure | Medical Centric Podcast @medicalcentric | — | Portugal | 83 |
| 11 | L’actualité de l'HFA 2026 vue par le président du GICC de la SFC | Cardio-online @cardio-online9873 | 1.7K | Francia | 84 |
| 17 | 🎄❄️ Navidad, frío y salud: Hidroterapia de contraste | Escuela de Salud Integrativa @escueladesaludintegrativa | 946 | España | 83 |
| 19 | What to Know About eGFR-Based Decision-Making #kidneyfunction | | 693 | Estados Unidos | 83 |
| 13 | Enlicitide Receives FDA Approval for Hypercholesterolemia Following CORALreef Trials | | 681 | Estados Unidos | 83 |
| 12 | Hypertension Artérielle HTA : Algorithme de Traitement 2025 Les Recommandations Dénervation Rénale | POSTERS VISION Santé et Médecine @postersvision | 602 | Canadá | 83 |
| 3 | SGLT2 EN ERC Beneficio en todos los estadios | ENSEÑANDO MEDICINA INTERNA @carloswaldomi | 383 | — | 85 |
| 6 | Hemodiálisis incremental como forma de inicio del tratamiento sustitutivo renal | Fundación Renal Española @fundacionrenale | 275 | España | 84 |
| 4 | AHA, ACC Release First-Ever Cardiovascular-Kidney-Metabolic Syndrome Guidelines | | 129 | Estados Unidos | 84 |
| 5 | Rethinking Advanced Heart Failure: Treat the Disease, Not the Symptoms | | 110 | Estados Unidos | 84 |
| 20 | Obinutuzumab Achieves 95.5% Remission in INS, May Shift Steroid-Sparing Treatment Strategies | | 109 | Estados Unidos | 83 |
| 15 | Efdoralprin Alfa vs Standard of Care in AATD: Phase 2 ElevAATe Results | | 82 | Estados Unidos | 83 |
| 2 | Cardiovascular, Renal & Hematologic Pharmacology | Section 3 – Brenner & Stevens’ Pharmacology (6th) | Last Minute Lecture @lastminutelecture | 75 | Estados Unidos | 85 |
| 18 | Moving the Needle in Medicine: Innovation, Leadership, and HF's Future, With Philip Adamson, MD, MSc | | 69 | Estados Unidos | 83 |
| 14 | Volixibat Improves Itch, Fatigue in PSC, Supporting “Patient-Centered” Care | | 59 | Estados Unidos | 83 |
| 10 | Continuous Ketone Monitoring May Guide SGLT2i Use in T1D | | 33 | Estados Unidos | 84 |
| 1 | Diuretic Drugs | Chapter 13 – Brenner & Stevens’ Pharmacology (6th) | Last Minute Lecture @lastminutelecture | 27 | Estados Unidos | 86 |
| 7 | Heart Failure Drug Therapy | Chapter 12 – Brenner & Stevens’ Pharmacology (6th) | Last Minute Lecture @lastminutelecture | 26 | Estados Unidos | 84 |
| 8 | Frontline Champions: Nurses as Drivers of Symptom-Based CKD-aP Care | | 12 | Estados Unidos | 84 |